Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses

Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infection. Surveillance for oseltamivir resistance is routinely performed to ensure the ongoing efficacy of oseltamivir against circulating viruses. Since the emergence of the pandemic 2009 A(H1N1) influe...

Full description

Saved in:
Bibliographic Details
Main Authors: Butler, Jeff, Hooper, Kathryn A., Petrie, Stephen, Lee, Raphael, Maurer-Stroh, Sebastian, Reh, Lucia, Guarnaccia, Teagan, Baas, Chantal, Xue, Lumin, Vitesnik, Sophie, Leang, Sook-Kwan, McVernon, Jodie, Kelso, Anne, Barr, Ian G., McCaw, James M., Bloom, Jesse D., Hurt, Aeron C.
Other Authors: Perez, Daniel R.
Format: Article
Language:English
Published: 2014
Subjects:
Online Access:https://hdl.handle.net/10356/101749
http://hdl.handle.net/10220/19748
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-101749
record_format dspace
spelling sg-ntu-dr.10356-1017492023-02-28T16:56:01Z Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses Butler, Jeff Hooper, Kathryn A. Petrie, Stephen Lee, Raphael Maurer-Stroh, Sebastian Reh, Lucia Guarnaccia, Teagan Baas, Chantal Xue, Lumin Vitesnik, Sophie Leang, Sook-Kwan McVernon, Jodie Kelso, Anne Barr, Ian G. McCaw, James M. Bloom, Jesse D. Hurt, Aeron C. Perez, Daniel R. School of Biological Sciences DRNTU::Science::Biological sciences::Microbiology::Virology Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infection. Surveillance for oseltamivir resistance is routinely performed to ensure the ongoing efficacy of oseltamivir against circulating viruses. Since the emergence of the pandemic 2009 A(H1N1) influenza virus (A(H1N1)pdm09), the proportion of A(H1N1)pdm09 viruses that are oseltamivir resistant (OR) has generally been low. However, a cluster of OR A(H1N1)pdm09 viruses, encoding the neuraminidase (NA) H275Y oseltamivir resistance mutation, was detected in Australia in 2011 amongst community patients that had not been treated with oseltamivir. Here we combine a competitive mixtures ferret model of influenza infection with a mathematical model to assess the fitness, both within and between hosts, of recent OR A(H1N1)pdm09 viruses. In conjunction with data from in vitro analyses of NA expression and activity we demonstrate that contemporary A(H1N1)pdm09 viruses are now more capable of acquiring H275Y without compromising their fitness, than earlier A(H1N1)pdm09 viruses circulating in 2009. Furthermore, using reverse engineered viruses we demonstrate that a pair of permissive secondary NA mutations, V241I and N369K, confers robust fitness on recent H275Y A(H1N1)pdm09 viruses, which correlated with enhanced surface expression and enzymatic activity of the A(H1N1)pdm09 NA protein. These permissive mutations first emerged in 2010 and are now present in almost all circulating A(H1N1)pdm09 viruses. Our findings suggest that recent A(H1N1)pdm09 viruses are now more permissive to the acquisition of H275Y than earlier A(H1N1)pdm09 viruses, increasing the risk that OR A(H1N1)pdm09 will emerge and spread worldwide. Published version 2014-06-13T04:03:49Z 2019-12-06T20:43:55Z 2014-06-13T04:03:49Z 2019-12-06T20:43:55Z 2014 2014 Journal Article Butler, J., Hooper, K. A., Petrie, S., Lee, R., Maurer-Stroh, S., Reh, L., et al. (2014). Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses. PLoS Pathogens, 10(4), e1004065-. 1553-7374 https://hdl.handle.net/10356/101749 http://hdl.handle.net/10220/19748 10.1371/journal.ppat.1004065 24699865 en PLoS pathogens © 2014 Butler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Science::Biological sciences::Microbiology::Virology
spellingShingle DRNTU::Science::Biological sciences::Microbiology::Virology
Butler, Jeff
Hooper, Kathryn A.
Petrie, Stephen
Lee, Raphael
Maurer-Stroh, Sebastian
Reh, Lucia
Guarnaccia, Teagan
Baas, Chantal
Xue, Lumin
Vitesnik, Sophie
Leang, Sook-Kwan
McVernon, Jodie
Kelso, Anne
Barr, Ian G.
McCaw, James M.
Bloom, Jesse D.
Hurt, Aeron C.
Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
description Oseltamivir is relied upon worldwide as the drug of choice for the treatment of human influenza infection. Surveillance for oseltamivir resistance is routinely performed to ensure the ongoing efficacy of oseltamivir against circulating viruses. Since the emergence of the pandemic 2009 A(H1N1) influenza virus (A(H1N1)pdm09), the proportion of A(H1N1)pdm09 viruses that are oseltamivir resistant (OR) has generally been low. However, a cluster of OR A(H1N1)pdm09 viruses, encoding the neuraminidase (NA) H275Y oseltamivir resistance mutation, was detected in Australia in 2011 amongst community patients that had not been treated with oseltamivir. Here we combine a competitive mixtures ferret model of influenza infection with a mathematical model to assess the fitness, both within and between hosts, of recent OR A(H1N1)pdm09 viruses. In conjunction with data from in vitro analyses of NA expression and activity we demonstrate that contemporary A(H1N1)pdm09 viruses are now more capable of acquiring H275Y without compromising their fitness, than earlier A(H1N1)pdm09 viruses circulating in 2009. Furthermore, using reverse engineered viruses we demonstrate that a pair of permissive secondary NA mutations, V241I and N369K, confers robust fitness on recent H275Y A(H1N1)pdm09 viruses, which correlated with enhanced surface expression and enzymatic activity of the A(H1N1)pdm09 NA protein. These permissive mutations first emerged in 2010 and are now present in almost all circulating A(H1N1)pdm09 viruses. Our findings suggest that recent A(H1N1)pdm09 viruses are now more permissive to the acquisition of H275Y than earlier A(H1N1)pdm09 viruses, increasing the risk that OR A(H1N1)pdm09 will emerge and spread worldwide.
author2 Perez, Daniel R.
author_facet Perez, Daniel R.
Butler, Jeff
Hooper, Kathryn A.
Petrie, Stephen
Lee, Raphael
Maurer-Stroh, Sebastian
Reh, Lucia
Guarnaccia, Teagan
Baas, Chantal
Xue, Lumin
Vitesnik, Sophie
Leang, Sook-Kwan
McVernon, Jodie
Kelso, Anne
Barr, Ian G.
McCaw, James M.
Bloom, Jesse D.
Hurt, Aeron C.
format Article
author Butler, Jeff
Hooper, Kathryn A.
Petrie, Stephen
Lee, Raphael
Maurer-Stroh, Sebastian
Reh, Lucia
Guarnaccia, Teagan
Baas, Chantal
Xue, Lumin
Vitesnik, Sophie
Leang, Sook-Kwan
McVernon, Jodie
Kelso, Anne
Barr, Ian G.
McCaw, James M.
Bloom, Jesse D.
Hurt, Aeron C.
author_sort Butler, Jeff
title Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
title_short Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
title_full Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
title_fullStr Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
title_full_unstemmed Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses
title_sort estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant a(h1n1)pdm09 influenza viruses
publishDate 2014
url https://hdl.handle.net/10356/101749
http://hdl.handle.net/10220/19748
_version_ 1759857390481571840